Mohammad Shadab Siddiqui MD
Advanced Endoscopic Interventional, Hepatology & Liver Transplantation
Assistant Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Join to View Full Profile
1200 E. Broad StreetWest Hospital, 14th FloorRichmond, VA 23298
Phone+1 804-828-2518
Fax+1 804-828-2992
Dr. Siddiqui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Virginia Commonwealth University Health SystemFellowship, Transplant Hepatology, 2011 - 2012
McGaw Medical Center of Northwestern UniversityFellowship, Gastroenterology, 2008 - 2011- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2005 - 2008
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2005
Certifications & Licensure
VA State Medical License 2011 - 2026
IL State Medical License 2005 - 2014
American Board of Internal Medicine Gastroenterology- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- Reply.Alok Baral, Mohammad Shadab Siddiqui
Clinical Gastroenterology and Hepatology. 2025-04-01 - Metabolic Flexibility Predicts Response to Saroglitazar in Liver Transplant Recipients With Metabolic Dysfunction-associated Steatotic Liver Disease.Kavin Parmar, Anh Tuan Bui, Taufik Momin, Idris Yakubu, Vaishali Patel
Transplantation. 2025-04-01 - Impact of Glucagon-like Peptide-1 Receptor Agonists on Metabolic Health in Liver Transplant Recipients.Idris Yakubu, Joseph Spengler, Perry Taylor, Michael LaPorte, Andrew Brown
Transplantation. 2025-03-25
Journal Articles
- Proton Pump Inhibitor Initiation and Withdrawal Affects Gut Microbiota and Readmission Risk in CirrhosisMichael Fuchs, Puneet Puri, Mohammad S Siddiqui, Douglas M Heuman, Jasmohan S Bajaj, Arun J Sanyal, Velimir Luketic, Richard K Sterling, Nature
Press Mentions
GLP-1RAs Confer ‘Metabolic Benefit,’ Lower Odds for MASLD After Liver TransplantationNovember 20th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
